<DOC>
	<DOCNO>NCT02445716</DOCNO>
	<brief_summary>This double-blind , randomize , placebo-controlled study . Seventy woman , age 35-75 year , treatment-emergent loss libido randomly allocate treatment Transdermal nanoemulsion Testosterone ( 500mcg ) deliver 300 mcg testosterone/day identical placebo nanoemulsion ( PLA ) 12 week .</brief_summary>
	<brief_title>Transdermal Testosterone Nanoemulsion Women Libido</brief_title>
	<detailed_description>The aim study investigate efficacy transdermal testosterone nanoemulsion ( TNT ) treatment SSRI/SNRI-emergent loss libido . The primary outcome measure evaluate change Sabbatsberg Sexual Self-rating Scale ( SSS ) total score 12 week . The 4-week frequency Satisfactory Sexual Events ( SSEs ) Female Sexual Distress Scale-Revised ( FSDS-R ) also evaluate .</detailed_description>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>body mass index 18 27 kg/m2 ; Diminished libido ; Sexual behavior complaint ; No evidence severe clinical depression ; General good health base history physical examination . past history neurological disorder ; Poor feeling partner ; Had receive pharmacotherapy depression within 8 week screen Taking medication know interfere normal sexual function ( αblockers βblockers ) ; Recent psychiatric systemic illness ; Uncontrolled hypertension ( blood pressure &gt; 160/95mmHg ) , Unstable cardiovascular disease , Genital bleeding ; Use psychoactive medication , alcohol excess consumption drug abuse ; Women go treatment acne , depression , dyspareunia .</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>